Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 1/2017

01-07-2017 | Letter to the Editor

Retinal vein occlusion and paroxysmal nocturnal hemoglobinuria

Authors: Marc Sorigue, Jordi Juncà, Elisa Orna, Nevena Romanic, Edurne Sarrate, Jordi Castellvi, Montse Soler, Ines Rodríguez-Hernandez, Evarist Feliu, Susana Ruiz

Published in: Journal of Thrombosis and Thrombolysis | Issue 1/2017

Login to get access

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disorder associated with increased risk for thrombosis and reduced life expectancy. Retinal vein occlusion (RVO) is a frequent cause of vision loss but its relationship with PNH has not been studied systematically. Patients followed up for RVO in our ophthalmology department were screened for the presence of a PNH clone in peripheral blood by means of flow cytometry. The presence of other well-documented risk factors for RVO was also analyzed. In a series of 110 patients (54 males, median age of 67) we found no evidence of PNH. Most patients (97/110) had cardiovascular risk factors and/or hyperhomocysteinemia (67/110). Inherited thrombophilias were rare (three confirmed cases). Therefore, PNH does not appear to play a role in the development of RVO. However, this finding does not necessarily apply to young patients and/or those with no conventional risk factors for RVO, due to the low number of patients in these subgroups in our population.
Literature
2.
go back to reference Takeda J, Miyata T, Kawagoe K, Iida Y, Endo Y, Fujita T, Takahashi M, Kitani T, Kinoshita T (1993) Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73:703–711CrossRefPubMed Takeda J, Miyata T, Kawagoe K, Iida Y, Endo Y, Fujita T, Takahashi M, Kitani T, Kinoshita T (1993) Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73:703–711CrossRefPubMed
3.
go back to reference Schrezenmeier H, Muus P, Socié G, Szer J, Urbano-Ispizua A, Maciejewski JP, Brodsky RA, Bessler M, Kanakura Y, Rosse W, Khursigara G, Bedrosian C, Hillmen P (2014) Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica 99:922–929. doi:10.3324/haematol.2013.093161 CrossRefPubMedPubMedCentral Schrezenmeier H, Muus P, Socié G, Szer J, Urbano-Ispizua A, Maciejewski JP, Brodsky RA, Bessler M, Kanakura Y, Rosse W, Khursigara G, Bedrosian C, Hillmen P (2014) Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica 99:922–929. doi:10.​3324/​haematol.​2013.​093161 CrossRefPubMedPubMedCentral
4.
go back to reference de Latour RP, Mary JY, Salanoubat C, Terriou L, Etienne G, Mohty M, Roth S, de Guibert S, Maury S, Cahn JY, Socié G, French Society of Hematology (2008) Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood 112:3099–3106. doi:10.1182/blood-2008-01-133918 CrossRefPubMed de Latour RP, Mary JY, Salanoubat C, Terriou L, Etienne G, Mohty M, Roth S, de Guibert S, Maury S, Cahn JY, Socié G, French Society of Hematology (2008) Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood 112:3099–3106. doi:10.​1182/​blood-2008-01-133918 CrossRefPubMed
6.
go back to reference Martí-Carvajal AJ, Anand V, Cardona AF, Solà I (2014) Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria. Cochrane Database Syst Rev 10:CD010340. doi:10.1002/14651858.CD010340 Martí-Carvajal AJ, Anand V, Cardona AF, Solà I (2014) Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria. Cochrane Database Syst Rev 10:CD010340. doi:10.​1002/​14651858.​CD010340
7.
8.
go back to reference Klein R, Klein BE, Moss SE, Meuer SM (2000) The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 98:133–141PubMedPubMedCentral Klein R, Klein BE, Moss SE, Meuer SM (2000) The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 98:133–141PubMedPubMedCentral
12.
14.
go back to reference Janssen MC, den Heijer M, Cruysberg JR, Wollersheim H, Bredie SJ (2005) Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost 93:1021–1026. doi:10.1160/TH04-11-0768 PubMed Janssen MC, den Heijer M, Cruysberg JR, Wollersheim H, Bredie SJ (2005) Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost 93:1021–1026. doi:10.​1160/​TH04-11-0768 PubMed
16.
go back to reference Sutherland DR, Kuek N, Davidson J, Barth D, Chang H, Yeo E, Bamford S, Chin-Yee I, Keeney M (2007) Diagnosing PNH with FLAER and multiparameter flow cytometry. Cytometry B 72:167–177. doi:10.1002/cyto.b.20151 CrossRef Sutherland DR, Kuek N, Davidson J, Barth D, Chang H, Yeo E, Bamford S, Chin-Yee I, Keeney M (2007) Diagnosing PNH with FLAER and multiparameter flow cytometry. Cytometry B 72:167–177. doi:10.​1002/​cyto.​b.​20151 CrossRef
18.
go back to reference Adamczuk YP, Iglesias Varela ML, Martinuzzo ME, Martinuzzo ME, Cerrato GS, Forastiero RR (2002) Central retinal vein occlusion and thrombophilia risk factors. Blood Coagul Fibrinolysis 13:623–626CrossRefPubMed Adamczuk YP, Iglesias Varela ML, Martinuzzo ME, Martinuzzo ME, Cerrato GS, Forastiero RR (2002) Central retinal vein occlusion and thrombophilia risk factors. Blood Coagul Fibrinolysis 13:623–626CrossRefPubMed
19.
go back to reference Schockman S, Glueck CJ, Hutchins RK, Patel J, Shah P, Wang P (2015) Diagnostic ramifications of ocular vascular occlusion as a first thrombotic event associated with factor V Leiden and prothrombin gene heterozygosity. Clin Ophthalmol 9:591–600. doi:10.2147/OPTH.S80714 CrossRefPubMedPubMedCentral Schockman S, Glueck CJ, Hutchins RK, Patel J, Shah P, Wang P (2015) Diagnostic ramifications of ocular vascular occlusion as a first thrombotic event associated with factor V Leiden and prothrombin gene heterozygosity. Clin Ophthalmol 9:591–600. doi:10.​2147/​OPTH.​S80714 CrossRefPubMedPubMedCentral
21.
24.
go back to reference Ageno W, Dentali F, De Stefano V, Barco S, Lerede T, Bazzan M, Piana A, Santoro R, Duce R, Poli D, Martinelli I, Siragusa S, Barillari G, Cattaneo M, Vidili G, Carpenedo M, Rancan E, Giaretta I, Tosetto A (2014) Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria phenotype in patients with splanchnic vein thrombosis. Thromb Res 133:1052–1055. doi:10.1016/j.thromres.2014.03.044 CrossRefPubMed Ageno W, Dentali F, De Stefano V, Barco S, Lerede T, Bazzan M, Piana A, Santoro R, Duce R, Poli D, Martinelli I, Siragusa S, Barillari G, Cattaneo M, Vidili G, Carpenedo M, Rancan E, Giaretta I, Tosetto A (2014) Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria phenotype in patients with splanchnic vein thrombosis. Thromb Res 133:1052–1055. doi:10.​1016/​j.​thromres.​2014.​03.​044 CrossRefPubMed
26.
go back to reference Rehak M, Krcova V, Slavik L, Fric E, Langova K, Ulehlova J, Rehak J (2010) The role of thrombophilia in patients with retinal vein occlusion and no systemic risk factors. Can J Ophthalmol 45:171–175. doi:10.3129/i09-273 CrossRefPubMed Rehak M, Krcova V, Slavik L, Fric E, Langova K, Ulehlova J, Rehak J (2010) The role of thrombophilia in patients with retinal vein occlusion and no systemic risk factors. Can J Ophthalmol 45:171–175. doi:10.​3129/​i09-273 CrossRefPubMed
Metadata
Title
Retinal vein occlusion and paroxysmal nocturnal hemoglobinuria
Authors
Marc Sorigue
Jordi Juncà
Elisa Orna
Nevena Romanic
Edurne Sarrate
Jordi Castellvi
Montse Soler
Ines Rodríguez-Hernandez
Evarist Feliu
Susana Ruiz
Publication date
01-07-2017
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 1/2017
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-017-1502-4

Other articles of this Issue 1/2017

Journal of Thrombosis and Thrombolysis 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.